X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/24/2869050/0/en/Kronos-Bio-to-Present-Clinical-Update-on-Phase-1-2-Trial-of-KB-0742-at-the-2024-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting.html
https://www.globenewswire.com/news-release/2024/03/21/2850114/0/en/Kronos-Bio-Reports-Recent-Business-Progress-and-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/03/07/2842738/0/en/Kronos-Bio-Announces-Restructuring-to-Focus-Resources-on-Clinical-Development-with-Extended-Cash-Runway.html
https://www.globenewswire.com//news-release/2024/03/05/2840963/0/en/Kronos-Bio-To-Present-Three-Posters-at-AACR-2024-Annual-Meeting.html
https://www.globenewswire.com//news-release/2024/02/27/2836438/0/en/Kronos-Bio-Announces-Participation-in-44th-Annual-Cowen-Health-Care-Conference.html
https://www.fiercebiotech.com/biotech/kronos-calls-time-cmo-cso-roles-part-c-suite-shakeup
https://www.globenewswire.com//news-release/2024/01/25/2816694/0/en/Kronos-Bio-Implements-New-Leadership-Structure-to-Drive-Pipeline-Advancement.html
https://www.fiercebiotech.com/biotech/kronos-discontinues-mid-stage-aml-trial-after-poor-patient-response
https://www.globenewswire.com//news-release/2023/12/18/2798137/0/en/Kronos-Bio-Announces-Pipeline-Update-and-p300-KAT-Inhibitor-Development-Candidate.html
https://www.globenewswire.com//news-release/2023/12/04/2789938/0/en/Kronos-Bio-Announces-Participation-in-H-C-Wainwright-4th-Annual-Precision-Oncology-Virtual-Conference.html
Market Place
Share 
